Diabetes comorbidities in low- and middle-income countries: An umbrella review.
Anastasia A Lam, Alexander Lepe, Sarah H Wild...
https://pubmed.ncbi.nlm.nih.gov/34386215/Actively Recruiting
Led by Khyber Medical University Peshawar · Updated on 2025-09-02
12744
Participants Needed
1
Research Sites
13 weeks
Total Duration
Researchers are evaluating a Participatory Learning and Action PLA based approach to prevent and control Type II Diabetes Mellitus TIIDM and Intermediate Hyperglycemia IHG in rural areas of Peshawar and Swabi, Pakistan. This approach builds on successful trials in Bangladesh and aims to adapt and assess the interventions effectiveness and cost-effectiveness specifically for these communities. TIIDM is a rapidly growing health issue worldwide, especially in low- and middle-income countries like Pakistan, making this study highly relevant to improving public health outcomes. The study involves forming community groups divided by gender where members meet monthly for 18 months to identify diabetes-related problems and develop strategies using collaborative activities such as discussions, role-play, and photo voice. A total of 64 groups per district will be formed, each including about 20-30 participants randomly selected from the community. A control group will receive usual care and routine awareness without the PLA intervention, allowing comparison of outcomes between groups. Participants will be engaged throughout the study period with regular meetings and interventions lasting 2 to 3 hours. Researchers will measure the prevalence of TIIDM and IHG, along with secondary outcomes like blood pressure, obesity, depression, and quality of life, after 18 months. The trials total duration includes follow-up to assess the two-year cumulative incidence of TIIDM. This design fosters community empowerment and aims to improve health behaviors and outcomes related to diabetes in these rural settings.
CONDITIONS
Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D]
P
Prof. Dr Zia Ul Haq, MBBS,MPH,PhD
K
Khalid Rahman, MBBS,MPH,PHD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Khyber Medical University Peshawar
Lead Sponsor
University of York
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 18 months
Participants join community groups that meet monthly to engage in participatory learning and action cycles focused on identifying and addressing diabetes-related health issues.
Monthly visits for 18 months
Duration - At 18 months after intervention start
Participants are assessed to evaluate the effectiveness and feasibility of the intervention, including health outcomes related to type 2 diabetes and its risk factors.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Anastasia A Lam, Alexander Lepe, Sarah H Wild...
https://pubmed.ncbi.nlm.nih.gov/34386215/Bryan J Weiner, Cara C Lewis, Cameo Stanick...
https://pubmed.ncbi.nlm.nih.gov/28851459/Amit Sapra, Priyanka Bhandari, Shivani Sharma...
https://pubmed.ncbi.nlm.nih.gov/32582485/Irfan Ullah, Md Saiful Islam, Sajjad Ali...
https://pubmed.ncbi.nlm.nih.gov/34639559/K Kroenke, R L Spitzer, J B Williams
https://pubmed.ncbi.nlm.nih.gov/11556941/Abdul Basit, Asher Fawwad, Huma Qureshi...
https://pubmed.ncbi.nlm.nih.gov/30082350/Edward Fottrell, Naveed Ahmed, Joanna Morrison...
https://pubmed.ncbi.nlm.nih.gov/30733182/Shahrum Vahedi
https://pubmed.ncbi.nlm.nih.gov/22952508/Khalid Rehman, Amber Tahir, Sara Imtiaz...
https://pubmed.ncbi.nlm.nih.gov/41088044/Maria Ishaq Khattak, Khalid Rehman, Saima Afaq...
https://pubmed.ncbi.nlm.nih.gov/42139267/Khyber Medical University Peshawar
Lead Sponsor
University of York
Collaborating Sponsor